The future of Pharma R&D

R&D has traditionally been and will continue to be (probably even more) crucial for the growth and future success of research-based pharma companies. The pharmaceutical industry has now entered a period of significant uncertainty and transition characterized by higher R&D costs, depleted pipelines and financial restriction to perform innovative research. The global credit crunch exacerbates all this with more and more layoffs and research budget cuts, but major crisis can sometimes produce major opportunities. 


    Related Conference of The future of Pharma R&D

    February 04-05, 2026

    18th International Conference on Gynecology

    Rome, Italy
    March 09-10, 2026

    13th World Machine Learning and Deep learning Conference

    Singapore City, Singapore
    March 24-25, 2026

    9th Global Congress on Spine and Spinal Disorders

    Paris, France
    March 26-27, 2026

    12th World Congress on Anesthesia and Critical Care

    Amsterdam, Netherlands
    April 15-16, 2026

    9th Annual Meeting on Diabetes and Endocrinology

    Tokyo, Japan
    April 20-21, 2026

    47th International Summit on Human Anatomy & Physiology

    Barcelona, Spain
    April 27-28, 2026

    40th International Conference on Psychiatry and Mental Health

    Amsterdam, Netherlands
    April 27-28, 2026

    37th World Congress on Neurorehabilitation

    Dubai, UAE
    May 25-26, 2026

    18th International Conference on Clinical Chemistry

    Zurich, Switzerland
    September 14-15, 2026

    6th World Medicine Congress

    Rome, Italy
    November 24-25, 2026

    6th International Conference on Medical Research and Development

    Amsterdam, Netherlands
    November 25-26, 2026

    22nd World Summit on Blockchain Technology

    Amsterdam, Netherlands

    The future of Pharma R&D Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in